Variant report
Variant | nsv891315 |
---|---|
Chromosome Location | chr8:112528407-112616415 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-422N16.3.1-4 | chr8:112555148-112555202 | ENSG00000253434.1 |
2 | lnc-RP11-422N16.3.1-4 | chr8:112554278-112554452 | ENSG00000253434.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531903903 | chr8:112538693-112538694 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548637359 | chr8:112538694-112538695 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562386969 | chr8:112538713-112538714 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143988218 | chr8:112538759-112538760 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74746845 | chr8:112538771-112538772 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570073719 | chr8:112538773-112538774 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545201950 | chr8:112538808-112538809 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111930495 | chr8:112538815-112538816 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539150338 | chr8:112538816-112538817 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2352158 | chr8:112538839-112538840 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs148640171 | chr8:112538856-112538857 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527401692 | chr8:112538883-112538884 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555400911 | chr8:112538888-112538889 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572301969 | chr8:112538953-112538954 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34543606 | chr8:112538957-112538958 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534226220 | chr8:112538994-112538995 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556035410 | chr8:112538997-112538998 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs28681647 | chr8:112539078-112539079 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs116258997 | chr8:112539092-112539093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143258535 | chr8:112539109-112539110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146678639 | chr8:112539142-112539143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139068944 | chr8:112539215-112539216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73707906 | chr8:112539225-112539226 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs562288582 | chr8:112539305-112539306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144541219 | chr8:112539325-112539326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200141499 | chr8:112539327-112539328 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184643263 | chr8:112539337-112539338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73326091 | chr8:112539345-112539346 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs190312848 | chr8:112539410-112539411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1160551 | chr8:112539456-112539457 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs181404331 | chr8:112539457-112539458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569710154 | chr8:112539458-112539459 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529123129 | chr8:112539459-112539460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549151624 | chr8:112539500-112539501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs28682951 | chr8:112539516-112539517 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs186258759 | chr8:112539529-112539530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558053974 | chr8:112539541-112539542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs28431296 | chr8:112539553-112539554 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs539822602 | chr8:112539578-112539579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556429628 | chr8:112539642-112539643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28712168 | chr8:112539654-112539655 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs74771992 | chr8:112539673-112539674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555931651 | chr8:112539693-112539694 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112040011 | chr8:112539698-112539699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572519799 | chr8:112539738-112539739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541343455 | chr8:112539744-112539745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189301059 | chr8:112539747-112539748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28579296 | chr8:112539793-112539794 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs543009575 | chr8:112539816-112539817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534786869 | chr8:112539829-112539830 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Bipolar disorder | 19114987 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:112538600-112539000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:112539000-112544000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:112539200-112540000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr8:112544000-112544600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr8:112551400-112552000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:112552800-112557800 | Weak transcription | Adipose Nuclei | Adipose |
7 | chr8:112557200-112558800 | Enhancers | Fetal Lung | lung |
8 | chr8:112557800-112558400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr8:112557800-112558600 | Strong transcription | Adipose Nuclei | Adipose |
10 | chr8:112558600-112560200 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr8:112575200-112577600 | Enhancers | Liver | Liver |
12 | chr8:112575800-112578400 | Enhancers | HepG2 | liver |
13 | chr8:112578200-112578400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr8:112593600-112593800 | Enhancers | Pancreas | Pancrea |
15 | chr8:112597000-112598400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr8:112611000-112611800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr8:112611400-112612000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr8:112611600-112611800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:112611600-112612200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr8:112611800-112612000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr8:112611800-112612800 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
22 | chr8:112615400-112615800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |